Update on BIG – UB Reporter: Need to know news and views for UB faculty and staff

In his 2014 State of the State Address, Gov. Andrew Cuomo announced a $105 million initiative combining the strengths of UB and the New York Genome Center (NYGC) with a goal of developing upstate New York as a national center for genomic medicine research and jobs. This effort involves companies focused on diagnostics and information technology to help grow the region’s and state’s economies and develop breakthroughs in personalized medicine.

The founding principals of the Buffalo Institute for Genomics and Data Analytics (BIG) last week offered an update on BIG’s inaugural year, including insight on successful collaborations with industry and how businesses can further engage, and on the institute’s blueprint for breathing new life into Buffalo by transforming medical diagnosis and treatment.

The lecture on Jan. 22 by Thomas Furlani, BIG interim executive director and director of UB’s Center for Computational Research (CCR); Norma Nowak, executive director of UB’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS); and Peter Winkelstein, executive director of the Institute for Healthcare Informatics (IHI), launched CBLS’ Commercialization Lecture Series for 2015. More than 100 people attended the BIG lecture, held in the CBLS, 701 Ellicott St. on the Downtown Campus.

The CBLS — one of the five original, statewide centers of excellence — is home to BIG, which oversees the engagement of CCR, CBLS, IHI and other key assets with the NYGC. BIG will provide operational support, facilities and services to aid in research and development, innovation, product development, entrepreneurial support and business development in fields requiring the use of high performance computing, informatics and biomedical research in genomic medicine.

“BIG is one aspect of this collaborative ‘village’ we are building in Buffalo,” Nowak said. “Collaboration with other industries is important for BIG to become integrated within the community and further critical, life-saving research.”

The collaboration is expected to yield nearly 500 jobs within five years. The partnership is already fostering symbiotic relationships among industry partners, UB faculty, other universities and nonprofit organizations such the NYGC to develop marketable, diagnostic, genomic assays for statin induced myopathy, multiple sclerosis and autism spectrum disorder that will guide the treatment strategies for these disorders.

via Update on BIG – UB Reporter: Need to know news and views for UB faculty and staff.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.